Table 1.
Respondent and Cancer Center Characteristics
| Characteristic | Participant Organizations (n = 44) |
Nonparticipant Organizations (n = 11) |
||
|---|---|---|---|---|
| No. | %* | No. | %* | |
| Respondents | ||||
| Primary respondent (n = 44) | ||||
| Pharmacy director (executive, director, manager) | 30 | 68 | ||
| Oncology pharmacist/specialist | 7 | 16 | ||
| Safety or operational leader | 4 | 9 | ||
| Not specified | 3 | 7 | ||
| Colleagues with whom primary respondent conferred (N = 89) | ||||
| Pharmacist or pharmacy director | 41 | 46 | ||
| Nurse, nurse practitioner, or nurse manager | 34 | 38 | ||
| Quality or medication safety director | 6 | 7 | ||
| Physician | 4 | 5 | ||
| Other† | 4 | 5 | ||
| Cancer centers | ||||
| Organization | ||||
| Matrix | 35 | 80 | 11 | 100 |
| Stand-alone | 9 | 20 | 0 | 0 |
| Location | ||||
| Northeast | 12 | 27 | 3 | 2 |
| Midwest | 11 | 25 | 2 | 18 |
| South | 9 | 21 | 4 | 36 |
| West | 12 | 27 | 2 | 18 |
| Not-for-profit ownership | 44 | 100 | 11 | 100 |
| Teaching status | 44 | 100 | 11 | 100 |
*
Percentages may not total 100 as a result of rounding.
†
Other includes chief medical officer (n = 2), pharmacy and therapeutics committee chair (n = 1), and physician assistant (n = 1).